Drug Transporter (DT) Information

General Information of DT
DT ID DTD0244
Gene Name SLC28A1
Protein Name Concentrative nucleoside transporter 1
Gene ID
9154
UniProt ID
O00337
TCDB ID
2.A.41.2.3
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 3TIJ_A

Identity: 36.854%

Minimized Score: -1108.04 kcal/mol

Detail: Structure Info

Synonyms CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1
DT Family Concentrative Nucleoside Transporter (CNT) Family ;
Tissue Specificity Expressed in kidney.
Function This sodium-dependent transporter exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective inhibition: adenosine, thymidine, cytidine, uridine >> guanosine, inosine.
Disease(s) Cholangiocarcinoma [ICD-11: 2C12.10]
Herpes simplex virus infection [ICD-11: 1F00]
Endogenous Substrate(s) 5'-deoxy-5'-fluorouridine; Na+
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation
Mutation-induced Structural Variation (MSV)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            4 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Cytarabine
 Approved Drug Info Acute myeloid leukemia 2A60 [1]
Gemcitabine
 Approved Drug Info Cholangiocarcinoma 2C12.10 [2]
Trifluridine
 Approved Drug Info Herpes simplex virus infection 1F00 [3]
Uridine
 Approved Drug Info Depression 6A8Z [4]
References
1 FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia. Oncotarget. 2016 Aug 2;7(31):49786-49799.
2 Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers (Basel). 2017 Nov 16;9(11).
3 Lonsurf, INN-trifluridine/tipiracil.
4 Electrophysiological recordings of CNT1 (SLC28A1) activity on Nanions SURFE2R N1.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.